Bright future or blind alley? car-t cell therapy for solid tumors

HIGHLIGHTS

• who: Kai Zhang and collaborators from the Arcellx Inc, United States Graduate School, Kunming Medical University, Kunming, Yunnan, China, Department of Traditional have published the article: Bright future or blind alley? CAR-T cell therapy for solid tumors, in the Journal: (JOURNAL) of November/21,/2022
• what: With safety concerns, an antibodybased switchable CAR T system was developed, which could strictly control the activity and antigen specificity of CAR T_cells by the formation of a switch-dependent immunological synapse .
• how: After that co-stimulatory molecules which enhance CAR T_cell activity were introduced into . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.